News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Stephen V Liu Shared NEOADAURA Results Published in JCO After ASCO25 Presentation
Stephen V Liu/X
Jun 8, 2025, 06:08

Stephen V Liu Shared NEOADAURA Results Published in JCO After ASCO25 Presentation

Stephen V Liu, Associate Professor of Medicine at Georgetown University, shared a post on X:

“NEOADAURA results published in JCO after ASCO 2025 presentation.
In patients with resectable EGFR-Mutated NSCLC, neoadjuvant osimertinib for 9 weeks led to MPR rate of 25%, osimertinib + chemotherapy MPR 26%, and placebo + chemotherapy MPR of 2%. EFS rates high, but most patients received adjuvant osimertinib.”

Title: Neoadjuvant Osimertinib for Resectable EGFR-Mutated Non-Small-Cell Lung Cancer

Journal: Journal of Clinical Oncology

Authors: Jianxing He, Masahiro Tsuboi, Walter Weder, Ke-Neng Chen, Maximilian J. Hochmair, Jin-Yuan Shih, Sung Yong Lee, Kang-Yun Lee, Nguyen Viet Nhung, Somcharoen Saeteng, Lunxu Liu, Ligang Xing, Nguyen Hoang Gia, Shuji Murakami, Yongtao Han, María Paz Saavedra, Seong Hoon Yoon, Carlos H.A. Teixeira, Carles Escriu, Alex Martinez-Marti, Collin M. Blakely, Yasushi Yatabe, Sanja Dacic, Yuri Rukazenkov, Xiangning Huang, Anupriya Dayal, Jamie E. Chaft

Read the full abstract.

NEOADAURA

More posts featuring Stephen V Liu on OncoDaily.

Alex Martínez-Martí Anupriya Dayal ASCO ASCO 2025 ASCO25 cancer Carles Escriu Carlos H.A. Teixeira Collin M. Blakely EGFR-mutant NSCLC Georgetown University Jamie E Chaft JCO Jianxing He Jin-Yuan Shih Kang-Yun Lee Ke-Neng Chen Ligang Xing Lunxu Liu María Paz Saavedra Masahiro Tsuboi Maximilian J. Hochmair NeoADAURA Nguyen Hoang Gia Nguyen Viet Nhung OncoDaily Oncology Sanja Dacic Seong Hoon Yoon Shuji Murakami Somcharoen Saeteng Stephen V Liu Sung Yong Lee Walter Weder Xiangning Huang Yasushi Yatabe Yongtao Han Yuri Rukazenkov
Special Coverage
Blog
Jun 26, 2025, 19:30
Getting Ready to Make the Most of Upcoming Events - EORTC
Blog
Jun 26, 2025, 19:22
Tobacco Taxation Gains Momentum in Kenya and Uganda Through Civil Society Mobilisation - UICC
Blog
Jun 26, 2025, 18:56
Late Breaking Abstract Submission Is Open - European Association of Neuro-Oncology
Blog
Jun 26, 2025, 18:44
Winan van Houdt: Pleased to Be Invited to the First Colombian Conference of Surgical Oncology
Positive
Jun 26, 2025, 18:34
Improving Life After Cancer for Survivors of Childhood and Adolescent Cancer - SIOP Europe
Blog
Jun 26, 2025, 18:18
Vote for Xploro to Win People’s Choice Award at CancerX Accelerator 2025 - World Child Cancer USA
Career
Jun 26, 2025, 18:06
Penn State Health Children's Hospital Is Seeking a Director for the Solid Tumor Program
Insight
Jun 26, 2025, 17:54
E. Shyam P. Reddy: Obesity Drugs Might also Tackle Migraine
Opinion
Jun 26, 2025, 17:47
MASCC 2025 Highlights: Global Crisis of Financial Toxicity in Cancer Care
Oncolibrary
Jun 26, 2025, 17:46
MASCC 2025 Highlights BVGH’s Global Solutions to Financial Toxicity in Cancer Care
Oncolibrary
Jun 26, 2025, 17:45
MASCC 2025 Highlights: Addressing Financial Toxicity in Cancer Supportive Care
Science
Jun 26, 2025, 17:29
Myeloma Paper of the Day, June 26th, Suggested by Robert Orlowski